---
title: "FLINES has been selected as a parts development supplier for GAC Hino"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233089703.md"
description: "According to the Zhitong Finance APP, FLINES announced that the company recently received a \"Supplier Selection Notification Letter\" from Guangqi Hino Motors Co., Ltd. (hereinafter referred to as \"Guangqi Hino\" or \"Customer\"). The company has officially been selected as a parts supplier for Guangqi Hino's heavy truck project, supplying gateway product components"
datetime: "2025-03-25T09:19:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233089703.md)
  - [en](https://longbridge.com/en/news/233089703.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233089703.md)
---

# FLINES has been selected as a parts development supplier for GAC Hino

According to the Zhitong Finance APP, FLINES (301191.SZ) announced that the company recently received a "Supplier Selection Notification Letter" from Guangzhou Automobile Hino Motor Co., Ltd. (hereinafter referred to as "Guangzhou Automobile Hino" or "customer"). The company has officially been selected as a parts supplier for Guangzhou Automobile Hino's heavy truck project, supplying gateway product components

### Related Stocks

- [301191.CN](https://longbridge.com/en/quote/301191.CN.md)

## Related News & Research

- [Daimler Truck's soft orders overshadow upbeat US outlook, shares fall](https://longbridge.com/en/news/295213608.md)
- [HEROMOTOCO: Q1 FY27 delivered 36% revenue growth and expanded market share across ICE, EV, and global segments](https://longbridge.com/en/news/295181288.md)
- [Cummins India's quarterly profit inches up as higher costs offset demand](https://longbridge.com/en/news/294968189.md)
- [Marvel Biosciences says MB-204 reverses cognitive, behavioral deficits in Fragile X mouse study](https://longbridge.com/en/news/294936790.md)
- [Clarity Pharmaceuticals reports two additional complete responses in SECuRE trial 8 GBq 67Cu-SAR-bisPSMA cohort](https://longbridge.com/en/news/294972498.md)